Terms: = Skin cancer AND SMO, Q99835, 6608, ENSG00000128602, SMOH, Gx
157 results:
1. Dynamic optical coherence tomography evaluation in locally advanced basal cell carcinoma during sonidegib treatment.
Cantisani C; Musolff N; Longo C; Di Guardo A; Rovaldi E; Rossi G; Sasso F; Farnetani F; Rega F; Bánvölgyiv A; Azzella G; Paolino G; Pellacani G
J Eur Acad Dermatol Venereol; 2024 May; 38(5):967-973. PubMed ID: 38270330
[TBL] [Abstract] [Full Text] [Related]
2. Immunohistochemical and Molecular Characteristics of Anogenital Papillary Hidradenomas.
Karpathiou G; Sim A; Picot T; Mekhzoumi K; Chauleur C; Péoc'h M
Am J Dermatopathol; 2024 Feb; 46(2):79-82. PubMed ID: 38055985
[TBL] [Abstract] [Full Text] [Related]
3. Signaling Pathways and Therapeutic Strategies in Advanced Basal Cell Carcinoma.
Vallini G; Calabrese L; Canino C; Trovato E; Gentileschi S; Rubegni P; Tognetti L
Cells; 2023 Oct; 12(21):. PubMed ID: 37947611
[TBL] [Abstract] [Full Text] [Related]
4. [The molecular genetic aspects of basal cell carcinoma from the position of population health preservation].
Khabriev RU; Sadykova RN; Mingazova EN; Bespyatykh JA
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2023 Sep; 31(5):946-950. PubMed ID: 37898882
[TBL] [Abstract] [Full Text] [Related]
5. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract] [Full Text] [Related]
6. Assessing the genetic risk of nodular melanoma using a candidate gene approach.
Stark MS; Sturm RA; Pan Y; Smit DJ; Kommajosyula V; Lee KJ; Jagirdar K; McLean C; Duffy DL; Soyer HP; Mar VJ
Br J Dermatol; 2024 Jan; 190(2):199-206. PubMed ID: 37766469
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation.
Villani A; Scalvenzi M; Micali G; Lacarrubba F; Genco L; Ruggiero A; Fornaro L; Guerrasio G; Potestio L
Expert Opin Drug Saf; 2023; 22(7):525-531. PubMed ID: 37326221
[TBL] [Abstract] [Full Text] [Related]
8. Targeting the Hedgehog pathway with novel Gli1 hydrophobic tagging degraders.
Li X; Sun R; Wu H; Zheng C; Long YQ
Bioorg Chem; 2023 Sep; 138():106649. PubMed ID: 37307715
[TBL] [Abstract] [Full Text] [Related]
9. Whole-exome sequencing of secondary tumors arising from nevus sebaceous revealed additional genomic alterations besides RAS mutations.
Kim YS; Park GS; Chung YJ; Lee JH
J Dermatol; 2023 Aug; 50(8):1072-1075. PubMed ID: 36938660
[TBL] [Abstract] [Full Text] [Related]
10. The Hedgehog/GLI signaling pathway activates transcription of Slug (Snail2) in melanoma cells.
Horák P; Kreisingerová K; Réda J; Ondrušová L; Balko J; Vachtenheim J; Žáková P; Vachtenheim J
Oncol Rep; 2023 Apr; 49(4):. PubMed ID: 36866769
[TBL] [Abstract] [Full Text] [Related]
11. Emerging Roles of Hedgehog Signaling in cancer Immunity.
Giammona A; Crivaro E; Stecca B
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674836
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of residual disease in periocular basal cell carcinoma following hedgehog pathway inhibition: Follow up to the VISORB trial.
Unsworth SP; Tingle CF; Heisel CJ; Eton EA; Andrews CA; Chan MP; Bresler SC; Kahana A
PLoS One; 2022; 17(12):e0265212. PubMed ID: 36455049
[TBL] [Abstract] [Full Text] [Related]
13. Novel Approaches in Non-Melanoma skin cancers-A Focus on Hedgehog Pathway in Basal Cell Carcinoma (BCC).
Chmiel P; Kłosińska M; Forma A; Pelc Z; Gęca K; Skórzewska M
Cells; 2022 Oct; 11(20):. PubMed ID: 36291078
[TBL] [Abstract] [Full Text] [Related]
14. Immune status does not independently influence cutaneous squamous cell carcinoma metastasis and death when stratified by tumor stage: A dual-center retrospective cohort analysis of primary N0 disease.
O'Connor DM; Murad F; Danesh MJ; Butler W; Smile TD; Ilori EO; Gastman BR; Vidimos A; Waldman AB; Schmults CD; Koyfman S; Ruiz ES
J Am Acad Dermatol; 2022 Dec; 87(6):1295-1302. PubMed ID: 36063987
[TBL] [Abstract] [Full Text] [Related]
15. Segmental basaloid follicular hamartomas derive from a post-zygotic smo p.L412F pathogenic variant and express hair follicle development-related proteins in a pattern that distinguish them from basal cell carcinomas.
Atzmony L; Ugwu N; Bercovitch LG; Robinson-Bostom L; Ko CJ; Myung P; Choate KA
Am J Med Genet A; 2022 Dec; 188(12):3525-3530. PubMed ID: 35972041
[TBL] [Abstract] [Full Text] [Related]
16. Periocular Pigmented Basal Cell Carcinomas: Clinicopathologic Features and Mutational Profile.
Hassanin F; Al Hussain H; Maktabi A; Adly N; Alsuabeyl M; Abedalthagafi M; Edward DP; Strianese D
Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):475-482. PubMed ID: 35699213
[TBL] [Abstract] [Full Text] [Related]
17. skin cancer biology and barriers to treatment: Recent applications of polymeric micro/nanostructures.
Khan NH; Mir M; Qian L; Baloch M; Ali Khan MF; Rehman AU; Ngowi EE; Wu DD; Ji XY
J Adv Res; 2022 Feb; 36():223-247. PubMed ID: 35127174
[TBL] [Abstract] [Full Text] [Related]
18. Synchronous Basal Cell Carcinoma and Squamous Cell Carcinoma of Nasal Vestibule With Novel Unique Variants Identified by Whole-exome Sequencing.
Ghlichloo I; Jin Z; Fan R; Tong C; Starostik P; Chien JR; Lai J
In Vivo; 2022; 36(1):251-257. PubMed ID: 34972722
[TBL] [Abstract] [Full Text] [Related]
19. GLI-1 polymorphisms of Hedgehog pathway as novel risk and prognostic biomarkers in melanoma patients.
Dunjic M; Lukic N; Djordjevic B; Uzelac B; Ostojic N; Supic G
Melanoma Res; 2022 Feb; 32(1):11-17. PubMed ID: 34939981
[TBL] [Abstract] [Full Text] [Related]
20. [Metastatic basal cell carcinoma with a smo gene mutation. A case report].
Zverev NP; Lyakhovets AA; Plaksa IL; Khmelkova DN; Isaev AA
Arkh Patol; 2021; 83(6):35-38. PubMed ID: 34859984
[TBL] [Abstract] [Full Text] [Related]
[Next]
